The Advisory Group at Starton Therapeutics provides strategic guidance and expert insights to support the development and commercialization of innovative transdermal therapies for cancer treatment. Comprised of diverse advisors with expertise in clinical research, health economics, and outcomes, the team collaborates to enhance the company's approach, ensuring that therapies meet patient needs and achieve optimal health benefits.
View all